172 related articles for article (PubMed ID: 24600121)
1. Seroprevalence of human parvovirus B19 in healthy blood donors.
Kumar S; Gupta RM; Sen S; Sarkar RS; Philip J; Kotwal A; Sumathi SH
Med J Armed Forces India; 2013 Jul; 69(3):268-72. PubMed ID: 24600121
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of human parvovirus B19 amongst North Indian blood donors - do current donor testing guidelines need a relook?
Raturi G; Kaur P; Kaur G
Transfus Apher Sci; 2018 Oct; 57(5):646-650. PubMed ID: 30087085
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.
Thomas I; Di Giambattista M; Gérard C; Mathys E; Hougardy V; Latour B; Branckaert T; Laub R
Vox Sang; 2003 May; 84(4):300-7. PubMed ID: 12757504
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Quantity of Parvovirus B19 DNA Among Blood Donors from a Regional Blood Center in Turkey.
Uskudar Guclu A; Yilmaz S; Baysallar M; Avci IY
Transfus Apher Sci; 2020 Aug; 59(4):102775. PubMed ID: 32439492
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.
Zadsar M; Aghakhani A; Banifazl M; Kazemimanesh M; Tabatabaei Yazdi SM; Mamishi S; Bavand A; Sadat Larijani M; Ramezani A
J Med Virol; 2018 Aug; 90(8):1318-1322. PubMed ID: 29663448
[TBL] [Abstract][Full Text] [Related]
6. The seroprevalence of parvovirus B19 antibody in blood donors at the National Blood Transfusion Center in Kinshasa.
Chabo Byaene A; Kabututu ZP; Abou Rayia DM; El-Sokkary MMA
J Med Virol; 2020 Mar; 92(3):288-294. PubMed ID: 31646654
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 seroprevalence in Turkish blood donors.
Göral Ş; Yenicesu İ; Bozdayı G; Duyan Çamurdan A; Altay Koçak A
Turk J Med Sci; 2018 Oct; 48(5):956-960. PubMed ID: 30384560
[TBL] [Abstract][Full Text] [Related]
8. Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors.
Hasanain RHA; Saleh RM; Attia FM; Gomaa HH
Indian J Hematol Blood Transfus; 2021 Apr; 37(2):309-312. PubMed ID: 33867739
[TBL] [Abstract][Full Text] [Related]
9. Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors.
Kishore J; Srivastava M; Choudhary N
Asian J Transfus Sci; 2010 Jul; 4(2):86-90. PubMed ID: 20859505
[TBL] [Abstract][Full Text] [Related]
10. Parvovirus B19 in South African blood donors.
Francois KL; Parboosing R; Moodley P
J Med Virol; 2019 Jul; 91(7):1217-1223. PubMed ID: 30840773
[TBL] [Abstract][Full Text] [Related]
11. Serological and Molecular Biological Studies of Parvovirus B19, Coxsackie B Viruses, and Adenoviruses as Potential Cardiotropic Viruses in Bulgaria.
Ivanova SK; Angelova SG; Stoyanova AP; Georgieva IL; Nikolaeva-Glomb LK; Mihneva ZG; Korsun NS
Folia Med (Plovdiv); 2016 Dec; 58(4):250-256. PubMed ID: 28068282
[TBL] [Abstract][Full Text] [Related]
12. [Seroprevalence versus Parvovirus B19 in blood donors].
Muñoz S; Alonso MA; Fernández MJ; Muñoz JL; García-Rodríguez JA
Enferm Infecc Microbiol Clin; 1998 Apr; 16(4):161-2. PubMed ID: 9646558
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.
Ke L; He M; Li C; Liu Y; Gao L; Yao F; Li J; Bi X; Lv Y; Wang J; Hirsch ML; Li W
Transfusion; 2011 Sep; 51(9):1909-18. PubMed ID: 21382040
[TBL] [Abstract][Full Text] [Related]
14. Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems.
Aktaş O; Aydin H; Uslu H
Turk J Med Sci; 2016 Feb; 46(2):368-73. PubMed ID: 27511498
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of parvovirus B19 antibodies and evidence of viremia among Nigerian patients with sickle cell anemia.
Iwalokun BA; Iwalokun SO; Hodonu SO
J Biomed Res; 2013 Jul; 27(4):272-82. PubMed ID: 23885266
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Human Parvovirus B19 in Neurological Patients: Findings from Region of Western Saudi Arabia.
Johargy AK; Jamal A; Ashgar SS; Ahmed FR; Kalkatawi MH
Curr Health Sci J; 2020; 46(1):16-22. PubMed ID: 32637161
[TBL] [Abstract][Full Text] [Related]
18. [Seroprevalence of IgG antibodies against parvovirus B19 among blood donors from Santiago, Chile].
Gaggero A; Rivera J; Calquín E; Larrañaga CE; León O; Díaz P; Gaggero N
Rev Med Chil; 2007 Apr; 135(4):443-8. PubMed ID: 17554452
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
20. A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS).
Ihara T; Furusyo N; Hayashi T; Toyoda K; Murata M; Hayashi J
Arch Virol; 2013 Dec; 158(12):2465-72. PubMed ID: 23775357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
